United-Guardian, Inc. is projected to rise to $8.12 by 2027, a +16% move from its current price of $7.02. UG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.90 | $7.02 | $7.15 | +0.05% |
| May 30 | $6.85 | $7.03 | $7.21 | +0.10% |
| May 31 | $6.82 | $7.03 | $7.25 | +0.14% |
| Jun 1 | $6.79 | $7.03 | $7.29 | +0.19% |
| Jun 2 | $6.76 | $7.04 | $7.32 | +0.24% |
| Jun 3 | $6.74 | $7.04 | $7.35 | +0.29% |
| Jun 4 | $6.72 | $7.04 | $7.38 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.72 | $7.04 | $7.38 | +0.33% |
| Week 2 | $6.61 | $7.07 | $7.55 | +0.67% |
| Week 3 | $6.54 | $7.09 | $7.69 | +1.00% |
| Week 4 | $6.48 | $7.11 | $7.81 | +1.34% |
| Week 5 | $6.43 | $7.14 | $7.93 | +1.68% |
| Week 6 | $6.38 | $7.16 | $8.03 | +2.02% |
| Week 7 | $6.35 | $7.19 | $8.13 | +2.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
United-Guardian, Inc. is a consumer defensive company that develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base.
It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines.
United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
UG is currently trading at $7.17, with a market capitalization of $32.94M, and ranked 4775. The stock sits in a niche consumer defensive space with a portfolio spanning cosmetic ingredients, medical lubricants, and sexual wellness products. The current price and the forecast show evolving upside over the long horizon while remaining sensitive to near-term volatility.
The year-by-year forecast outlines a path of rising averages and sizable potential returns, signaling meaningful long-term appreciation amidst varying near-term sentiment.
A major floor 11.5% below — a decisive break under it would weaken the trend.
The nearest floor, 5.3% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 11.3% above — clearing it would confirm fresh momentum.
Key UG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.08 | Sell | $7.08 | Sell |
| MA 10 | $7.08 | Sell | $7.07 | Sell |
| MA 20 | $7.07 | Sell | $7.03 | Sell |
| MA 50 | $6.79 | Buy | $6.88 | Buy |
| MA 100 | $6.70 | Buy | $6.82 | Buy |
| MA 200 | $6.92 | Buy | $7.12 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.17 | Neutral |
| Stoch RSI (14) | 13.51 | Buy |
| CCI (20) | -30.83 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 2.18 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 47.08 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 7.10 | Sell |
| ADX (14) | 10.67 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture carries a bullish tilt in the near term, with RSI14 at 60. The stock trades around key averages, with SMA50 at $6.77 and SMA200 at $6.93. A defined support at $6.54 and resistance at $7.43 frame a trading range near the current level. The 30-day range spans from $6.34 to $8.11, highlighting a constructive but zone-bound setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.13 | $7.02 | $8.77 | 0% | Neutral | |
| $6.64 | $8.12 | $10.41 | +16% | Neutral | |
| $7.68 | $9.57 | $12.58 | +36% | Bullish | |
| $8.82 | $11.16 | $14.98 | +59% | Bullish | |
| $10.25 | $13.14 | $17.95 | +87% | Bullish | |
| $10.88 | $14.12 | $19.58 | +101% | Bullish | |
| $11.50 | $15.09 | $21.23 | +115% | Bullish | |
| $12.14 | $16.10 | $22.93 | +129% | Bullish | |
| $12.33 | $16.51 | $23.80 | +135% | Bullish | |
| $13.98 | $18.90 | $27.54 | +169% | Bullish | |
| $20.39 | $28.74 | $43.88 | +309% | Bullish | |
| $39.09 | $59.09 | $96.68 | +742% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.13 | $7.02 | $8.20 | +0.00% |
| June 2026 | $6.09 | $7.10 | $8.45 | +1.16% |
| July 2026 | $6.25 | $7.33 | $8.80 | +3.23% |
| August 2026 | $6.18 | $7.28 | $8.81 | -0.66% |
| September 2026 | $6.04 | $7.14 | $8.68 | -1.97% |
| October 2026 | $6.09 | $7.23 | $8.85 | +1.32% |
| November 2026 | $6.12 | $7.29 | $8.95 | +0.73% |
| December 2026 | $5.95 | $7.11 | $8.77 | -2.47% |
Click any year to see its month-by-month UG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, UG could reach as high as $8.77, with a base case around $7.02 and support toward $6.13 — roughly 0% from $7.02. A consolidation phase looks the most probable path here.
Expect UG to range from $6.64 to $10.41 through 2027. The $8.12 average target implies a +16% move from current prices. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
The UG price prediction for 2028 points to an average of $9.57 (low $7.68, high $12.58) — a potential gain of +36% on today's $7.02. Buyers look set to stay in control over this stretch.
In 2029, UG is projected to trade between $8.82 and $14.98, averaging $11.16 — a potential gain of +59% from today's $7.02. That is up +17% on the projected 2028 average. Momentum favours further upside here.
United-Guardian, Inc.'s 2030 outlook centres on $13.14, within a $10.25 to $17.95 range. That is up +18% on the projected 2029 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, UG could reach as high as $19.58, with a base case around $14.12 and support toward $10.88 — roughly +101% from $7.02. Momentum favours further upside here.
Expect UG to range from $11.50 to $21.23 through 2032. The $15.09 average target implies a +115% move from current prices. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The UG price prediction for 2033 points to an average of $16.10 (low $12.14, high $22.93) — a potential gain of +129% on today's $7.02. Momentum favours further upside here.
In 2034, UG is projected to trade between $12.33 and $23.80, averaging $16.51 — a potential gain of +135% from today's $7.02. That is up +3% on the projected 2033 average. Buyers look set to stay in control over this stretch.
United-Guardian, Inc.'s 2035 outlook centres on $18.90, within a $13.98 to $27.54 range. That is up +14% on the projected 2034 average. That marks a +169% change versus current levels. Momentum favours further upside here.
By 2040, UG could reach as high as $43.88, with a base case around $28.74 and support toward $20.39 — roughly +309% from $7.02. Buyers look set to stay in control over this stretch.
Expect UG to range from $39.09 to $96.68 through 2050. The $59.09 average target implies a +742% move from current prices. That is up +106% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in UG today (≈ 142.450142 UG) could be worth
$8,417.05
+$7,417.05 (+742%) by 2050 · US Dollar
Based on the average projected UG price of $59.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UGwould be worth at today's price.
$1,000 invested in UG on May 27, 2025 (≈ 117.785633 UG) would be worth
$826.86
-$173.14 (-17.3%) today · 0.83× · US Dollar
Based on a UG entry price of $8.49 vs. today's $7.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.04 | $997.16 | -0.3% |
| 1 month ago | $6.97 | $1,007.17 | +0.7% |
| 3 months ago | $6.6 | $1,063.64 | +6.4% |
| 6 months ago | $5.79 | $1,212.44 | +21.2% |
| 1 year ago | $8.49 | $826.86 | -17.3% |
| All time (5.0y) ago | $15.52 | $452.32 | -54.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UG forecast.
Our base-case forecast reaches $14.00 around 2031.
Implied market cap at $14.00: $64.32M
Over the multi-year horizon, the forecast shows substantial upside. The 2026 average is $7.17, with a min of $6.13 and a max of $8.98 (ROI 0) and neutral sentiment. By 2030, the average rises to $13.91 with a min of $10.85 and a max of $19.00 (ROI 94) and bullish momentum.
The path continues higher into 2040, with an average of $31.14, a min of $22.09, and a max of $47.56 (ROI 334.4) and bullish sentiment, and culminates in 2050 with an average of $64.86, a min of $42.91, and a max of $106.14 (ROI 804.7) and bullish sentiment. These are estimates reflecting projected gains across years, tied to a bullish long-range view but not guarantees. Current price action and the near-term range should be weighed against the larger forecast as conditions evolve.
Tap a question to reveal the answer.
2030 avg $13.91, min $10.85, max $19.00; ROI 94; sentiment BULLISH.
Forecasts show positive ROI in multiple years: 2027 ROI 17.9; 2028 ROI 39.8; 2029 ROI 63.2; 2030 ROI 94; 2031 ROI 108.6; 2032 ROI 122.8; 2033 ROI 140.4; 2034 ROI 146.3; 2035 ROI 183.8; 2040 ROI 334.4; 2050 ROI 804.7.
The max in 2050 is $106.14, which is above $80.
The current price is $7.17.
2040 avg $31.14, min $22.09, max $47.56; ROI 334.4; sentiment BULLISH.
United-Guardian, Inc. Community Discussion
0Share your United-Guardian, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.